Large gap with delayed quotes
|
Last quote
07/01/2025
-
22:15:00
|
Bid
07/01/2025 -
22:00:00
|
Bid Volume |
Ask
07/01/2025 -
22:00:00
|
Ask Volume |
|---|---|---|---|---|
|
76.32
+1.71
(
+2.29% )
|
76.38
|
300 |
76.44
|
1,700 |
Analysis date: 27.06.2025
Global Evaluation
Neutral
Neutral
The stock is classified in the neutral zone since 09.05.2025.
Interest
Very strong
Very strong
Four stars since 09.05.2025.
Earnings Rev Trend
0.10
0.10
Compared to seven weeks ago, the analysts have not significantly revised their earnings per share estimates (changes between +1% and -1% are considered neutral). But the last significant trend is positive since 11.04.2025 at a price of 60.04.
Evaluation
Strongly undervalued
Strongly undervalued
Based on its growth potential and our own criteria, we believe the share price is currently undervalued.
MT Tech Trend
Positive
Positive
The forty day technical trend is positive since 29.04.2025.
4wk Rel Perf
4.30%
4.30%
The four-week dividend-adjusted overperformance versus SP500 is 4.30%.
Sensibility
High
High
The stock has been on the high-sensitivity level since 07.02.2025.
Bear Market Factor
Low
Low
On average, the stock has a tendency to minimize the drops in the index by -0.19%.
Bad News Factor
Low
Low
When the stock's pressure is specific, the market sanction on average is 3.86%.
Mkt Cap in $bn
3.55
3.55
With a market capitalization between $2 & $8bn, HAEMONETICS is considered a mid-cap stock.
G/PE Ratio
1.14
1.14
A ratio (Forecasted Growth + Estimated Dividend Yield/ Estimated Price Earnings) higher than 0.9 indicates that the stock's price presents a discount to growth of
LT P/E
13.28
13.28
The estimated PE is for the year 2027.
LT Growth
12.37%
12.37%
The annualized growth estimate is for the current year to 2027.
Avg. Nb analysts
9
9
Over the last seven weeks, an average of 9 analysts provided earnings per share estimates.
Dividend Yield
2.71%
2.71%
The twelve month estimated dividend yield represents 35.98% of earnings forecasts.
Beta
69
69
For 1% of index variation, the stock varies on average by 0.69%.
Correlation
0.34
0.34
Stock movements are strongly independent of index variations.
Value at Risk
19.29
19.29
The value at risk is estimated at USD 19.29. The risk is therefore 26.14%. This value is based on the historical volatility for a medium time period (1 month) with a confidence of 95%.
First Analysis Date
09.11.2005
09.11.2005